Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

PetVivo Holdings Inc

Healthcare US PETV

0.792USD
-(-%)

Last update at 2026-03-09T20:00:00Z

Day Range

0.700.79
LowHigh

52 Week Range

0.553.60
LowHigh

Fundamentals

  • Previous Close 0.79
  • Market Cap16.78M
  • Volume2400
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-10.36749M
  • Revenue TTM0.96M
  • Revenue Per Share TTM0.08
  • Gross Profit TTM -0.08557M
  • Diluted EPS TTM-0.97

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -8.71761M -5.01499M -3.52278M -2.08273M -4.75776M
Minority interest - - - - 0.00000M
Net income -8.70176M -4.94178M -3.75137M -2.11492M -4.75776M
Selling general administrative 5.02M 3.15M 1.77M 1.23M 3.60M
Selling and marketing expenses 3.41M 1.35M 0.09M 0.17M 0.04M
Gross profit 0.39M -0.08557M 0.00188M -0.01612M -0.07794M
Reconciled depreciation 0.11M 0.07M 0.09M 0.56M 0.65M
Ebit -8.84789M -5.05653M -1.95899M -2.01613M -4.56901M
Ebitda -8.73345M -5.02306M -1.87228M -1.42532M -3.92209M
Depreciation and amortization 0.11M 0.03M 0.09M 0.59M 0.65M
Non operating income net other - - -1.33520M -0.03442M -0.08495M
Operating income -8.73345M -5.05653M -1.95899M -2.01613M -4.67281M
Other operating expenses 9.65M 5.17M 1.97M 1.99M 4.57M
Interest expense 0.02M 0.04M 0.23M 0.03M 0.08M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.02M - - - -
Net interest income 0.02M 0.00985M -0.22859M -0.03218M -0.08495M
Extraordinary items - - - - 0.00000M
Non recurring - - - 0.03M 0.10M
Other items - - - - 0.00000M
Income tax expense -0.01584M -0.07321M 0.23M 0.03M 0.08M
Total revenue 0.92M 0.12M 0.01M 0.00359M 0.08M
Total operating expenses 9.12M 4.97M 1.96M 1.97M 4.49M
Cost of revenue 0.53M 0.20M 0.01M 0.02M 0.08M
Total other income expense net 0.02M 0.04M -1.56379M -0.06660M -0.10380M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -8.71761M -5.01499M -3.52278M -2.08273M -4.75776M
Net income applicable to common shares - -5.01499M -3.52278M -2.08273M -4.75776M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 2.44M 7.43M 0.84M 0.52M 0.69M
Intangible assets 0.04M 0.05M 0.03M 0.06M 0.59M
Earning assets - - - - -
Other current assets 0.49M 0.55M 0.12M 0.20M 0.04M
Total liab 1.71M 1.44M 1.73M 1.56M 1.54M
Total stockholder equity 0.73M 5.99M -0.89698M -1.03617M -0.84482M
Deferred long term liab - - 0.28M - 0.00000M
Other current liab 0.79M 0.78M 0.23M 0.45M 0.58M
Common stock 0.01M 0.00999M 0.00680M 0.02M 0.02M
Capital stock 0.01M 0.00999M 0.00680M 0.02M 0.02M
Retained earnings -71.84403M -63.12642M -58.11143M -54.58865M -52.50591M
Other liab - - - - 0.00000M
Good will - - - - 0.00000M
Other assets - 0.01M 0.29M 0.00820M 0.00820M
Cash 0.48M 6.11M 0.02M 0.00089M 0.00646M
Cash and equivalents - - - - -
Total current liabilities 1.45M 1.17M 1.41M 1.15M 1.54M
Current deferred revenue -0.00694M - - - -
Net debt -0.12998M -5.77398M 0.71M 0.51M 0.10M
Short term debt 0.09M 0.07M 0.41M 0.10M 0.10M
Short long term debt 0.00694M 0.00655M 0.38M 0.08M 0.10M
Short long term debt total 0.35M 0.33M 0.73M 0.51M 0.10M
Other stockholder equity 72.56M 69.10M 57.21M 53.53M 51.75M
Property plant equipment - 0.61M 0.37M 0.26M 0.04M
Total current assets 1.42M 6.76M 0.15M 0.20M 0.06M
Long term investments - - - - 0.00000M
Net tangible assets - 5.94M -0.92491M -1.09478M -1.43463M
Short term investments - - - 0.00150M 0.00000M
Net receivables 0.09M 0.00260M 0.00000M 0.05M 0.00016M
Long term debt 0.02M 0.03M 0.20M 0.29M 0.00000M
Inventory 0.37M 0.10M 0.00000M -0.05350M 0.01M
Accounts payable 0.59M 0.32M 0.77M 0.60M 0.85M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - -0.11159M -0.11245M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - 0.00680M 0.02M 0.63M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - -58.11143M -54.58865M -52.50591M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 0.03M 0.01M 0.29M 0.00820M 0.00820M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 1.01M 0.67M 0.69M 0.33M 0.64M
Capital lease obligations 0.32M 0.30M 0.16M 0.15M 0.00000M
Long term debt total - - - 0.29M 0.00000M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -0.42393M -0.18318M -0.16016M -0.00150M -0.10381M
Change to liabilities 0.26M 0.14M 0.17M 0.05M 0.20M
Total cashflows from investing activities -0.42393M -0.18318M -0.16016M -0.06520M -0.10381M
Net borrowings -0.00640M -0.08168M 0.40M 0.23M 0.21M
Total cash from financing activities 1.59M 10.44M 1.22M 0.57M 0.61M
Change to operating activities -0.06645M -0.24448M -0.29059M 0.09M 0.02M
Net income -8.71761M -5.01499M -3.52278M -2.08273M -4.75776M
Change in cash -5.63151M 6.08M 0.01M 0.00412M -0.23087M
Begin period cash flow 6.11M 0.02M 0.01M 0.00646M 0.24M
End period cash flow 0.48M 6.11M 0.02M 0.01M 0.00646M
Total cash from operating activities -6.79448M -4.17496M -1.04733M -0.49659M -0.73645M
Issuance of capital stock 1.53M 10.20M 0.37M 0.34M 0.40M
Depreciation 0.11M 0.07M 0.09M 0.56M 0.65M
Other cashflows from investing activities - - -0.01948M -0.03090M -0.07669M
Dividends paid - - - - 0.00000M
Change to inventory -0.27197M -0.09831M -0.01042M 0.01M -0.06488M
Change to account receivables -0.08409M -0.00260M 0.00100M -0.00100M 1.48M
Sale purchase of stock - - 0.77M 0.34M 0.40M
Other cashflows from financing activities 0.07M 0.32M 0.87M 0.29M 0.28M
Change to netincome 1.97M 0.98M 2.33M 0.89M 1.82M
Capital expenditures 0.42M 0.18M 0.16M 0.08M 0.11M
Change receivables - - 0.00100M -0.00100M 0.00000M
Cash flows other operating - - 1.41M 0.07M 1.28M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - 0.01M 0.00412M -0.23087M
Change in working capital -0.16168M -0.20051M -0.11493M 0.10M 0.12M
Stock based compensation 1.46M 0.70M 0.45M 0.86M 1.64M
Other non cash items 0.51M 0.27M 0.72M -0.04771M 1.43M
Free cash flow -7.21842M -4.35814M -1.20749M -0.57277M -0.84225M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PETV
PetVivo Holdings Inc		 - -% 0.79 - - 17.33 12.00 13.70 -1.1869
ABT
Abbott Laboratories		 -2.1 1.86% 110.55 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -7.27 1.99% 358.65 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -1.45 1.59% 89.89 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.94 2.70% 69.96 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

PetVivo Holdings Inc

5251 Edina Industrial Boulevard, Minneapolis, MN, United States, 55439

Key Executives

Name Title Year Born
Mr. John Lai CEO, Pres & Director 1962
Mr. Robert J. Folkes Chief Financial Officer 1963
Mr. Randall A. Meyer Chief Operating Officer 1964
Mr. Randy Wenthold Chief Science Officer NA
Mr. John F. Dolan Gen. Counsel, Chief Bus. Devel. Officer & Sec. 1965
Mr. Gary DeMel Exec. VP of Bus. Devel. 1957
Mr. Russell Siakel Director of Marketing NA
Mr. Mark Middleton National Director of Sales NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.